Picture of Biomerica logo

BMRA — Biomerica News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Biomerica Reports 208% Increase In Q3 2021 Sales Over Q3 2020

April 15 (Reuters) - Biomerica Inc  BMRA.O :
    * BIOMERICA REPORTS 208% INCREASE IN Q3 FISCAL 2021 SALES,
OVER Q3
FISCAL 2020
    * Q3 SALES $3.62 MILLION
    * INFOODS IBS DIAGNOSTIC-GUIDED THERAPY CLINICAL TRIAL
EXPECTING
TOP LINE TRIAL RESULTS BY THIRD CALENDAR QUARTER OF 2021
    * NET LOSS FOR FISCAL Q3 2021 WAS $1.84 MILLION COMPARED TO
A NET
LOSS OF $0.86 MILLION FOR SAME PERIOD IN FISCAL 2020

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXlKRbD
Further company coverage:  BMRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biomerica

See all news